TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Bioform AB
Closing information (x1000 EUR)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
111
|
144 | |
| Financial expenses |
1
|
1 | |
| Earnings before taxes |
42
|
44 | |
| EBITDA |
46
|
49 | |
| Total assets |
174
|
213 | |
| Current assets |
161
|
154 | |
| Current liabilities |
10
|
15 | |
| Equity capital |
151
|
148 | |
| - share capital |
8
|
9 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
86.8%
|
69.5% | |
| Turnover per employee |
111
|
144 | |
| Profit as a percentage of turnover |
37.8%
|
30.6% | |
| Return on assets (ROA) |
24.7%
|
21.1% | |
| Current ratio |
1610.0%
|
1026.7% | |
| Return on equity (ROE) |
27.8%
|
29.7% | |
| Change turnover |
-19
|
6 | |
| Change turnover % |
-2%
|
-15%
|
4% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.